Predicting Functional Outcome Based on Linked Data After Acute Ischemic Stroke: S-SMART Score.


Journal

Translational stroke research
ISSN: 1868-601X
Titre abrégé: Transl Stroke Res
Pays: United States
ID NLM: 101517297

Informations de publication

Date de publication:
12 2020
Historique:
received: 06 02 2020
accepted: 06 04 2020
revised: 30 03 2020
pubmed: 20 4 2020
medline: 25 2 2023
entrez: 20 4 2020
Statut: ppublish

Résumé

Prediction of outcome after stroke may help clinicians provide effective management and plan long-term care. We aimed to develop and validate a score for predicting good functional outcome available for hospitals after ischemic stroke using linked data. A total of 22,005 patients with acute ischemic stroke from the Clinical Research Center for Stroke Registry between July 2007 and December 2014 were included in the derivation group. We assessed functional outcomes using a modified Rankin scale (mRS) score at 3 months after ischemic stroke. We identified predictors related to good 3-month outcome (mRS score ≤ 2) and developed a score. External validations (geographic and temporal validations) of the developed model were performed. The prediction model performance was assessed using the area under the receiver operating characteristic curve (AUC) and the calibration test. Stroke severity, sex, stroke mechanism, age, pre-stroke mRS, and thrombolysis/thrombectomy treatment were identified as predictors for 3-month good functional outcomes in the S-SMART score (total 34 points). Patients with higher S-SMART scores had an increased likelihood of a good outcome. The AUC of the prediction score was 0.805 (0.798-0.811) in the derivation group and 0.812 (0.795-0.830) in the geographic validation group for good functional outcome. The AUC of the model was 0.812 (0.771-0.854) for the temporal validation group. Moreover, they had good calibration. The S-SMART score is a valid and useful tool to predict good functional outcome following ischemic stroke. This prediction model may assist in the estimation of outcomes to determine care plans after stroke.

Identifiants

pubmed: 32306239
doi: 10.1007/s12975-020-00815-y
pii: 10.1007/s12975-020-00815-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1296-1305

Subventions

Organisme : Ministry of Health and Welfare
ID : HI 16C1078
Pays : International
Organisme : Asan Institute for Life Sciences, Asan Medical Center
ID : 2015-9003
Pays : International

Auteurs

Tae Jung Kim (TJ)

Department of Neurology, Seoul National University Hospital, 101 Daehakno, Jongno-Gu, Seoul, 03080, South Korea.

Ji Sung Lee (JS)

Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Mi-Sun Oh (MS)

Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, South Korea.

Ji-Woo Kim (JW)

Health Insurance Review and Assessment Service, Wonju, South Korea.

Jae Sun Yoon (JS)

Department of Neurology, Seoul National University Hospital, 101 Daehakno, Jongno-Gu, Seoul, 03080, South Korea.

Jae-Sung Lim (JS)

Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, South Korea.

Chan-Hyuk Lee (CH)

Department of Neurology, Seoul National University Hospital, 101 Daehakno, Jongno-Gu, Seoul, 03080, South Korea.

Heejung Mo (H)

Department of Neurology, Seoul National University Hospital, 101 Daehakno, Jongno-Gu, Seoul, 03080, South Korea.

Han-Yeong Jeong (HY)

Department of Neurology, Seoul National University Hospital, 101 Daehakno, Jongno-Gu, Seoul, 03080, South Korea.

Yerim Kim (Y)

Department of Neurology, Kangdong Sacred Heart Hospital, Seoul, South Korea.

Sang-Hwa Lee (SH)

Department of Neurology, Hallym University College of Medicine, Chuncheon, South Korea.

Keun-Hwa Jung (KH)

Department of Neurology, Seoul National University Hospital, 101 Daehakno, Jongno-Gu, Seoul, 03080, South Korea.

Log Young Kim (LY)

Health Insurance Review and Assessment Service, Wonju, South Korea.

Mi Ra An (MR)

Health Insurance Review and Assessment Service, Wonju, South Korea.

Young Hee Park (YH)

Health Insurance Review and Assessment Service, Wonju, South Korea.

Tae Seon Lee (TS)

Health Insurance Review and Assessment Service, Wonju, South Korea.

Yun Jung Heo (YJ)

Health Insurance Review and Assessment Service, Wonju, South Korea.

Sang-Bae Ko (SB)

Department of Neurology, Seoul National University Hospital, 101 Daehakno, Jongno-Gu, Seoul, 03080, South Korea.

Kyung-Ho Yu (KH)

Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, South Korea.

Byung-Chul Lee (BC)

Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, South Korea.

Byung-Woo Yoon (BW)

Department of Neurology, Seoul National University Hospital, 101 Daehakno, Jongno-Gu, Seoul, 03080, South Korea. bwyoon@snu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH